C4 Therapeutics
CCCC
CCCC
106 hedge funds and large institutions have $476M invested in C4 Therapeutics in 2024 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 29 increasing their positions, 27 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
15% more funds holding
Funds holding: 92 → 106 (+14)
7% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 27
10.92% less ownership
Funds ownership: 95.79% → 84.87% (-11%)
Holders
106
Holding in Top 10
2
Calls
$6.88M
Puts
$4.6M
Top Buyers
| 1 | +$57.2M | |
| 2 | +$11.7M | |
| 3 | +$10.1M | |
| 4 |
Two Sigma Investments
New York
|
+$9.57M |
| 5 |
Goldman Sachs
New York
|
+$9.54M |
Top Sellers
| 1 | -$23M | |
| 2 | -$8.62M | |
| 3 | -$7.98M | |
| 4 |
BlackRock
New York
|
-$7.34M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$6.91M |